Valuation Integra LifeSciences Holdings Corporation
Stocks
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
21:00:00 15/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 15.69 USD | -0.13% |
|
-6.16% | +26.33% |
Company Valuation: Integra LifeSciences Holdings Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,674 | 4,683 | 3,405 | 1,750 | 967.4 | 1,222 | - | - |
| Change | - | -17.47% | -27.3% | -48.6% | -44.72% | 26.3% | - | - |
| Enterprise Value (EV) 1 | 6,707 | 5,670 | 4,605 | 3,285 | 2,563 | 2,711 | 2,507 | 2,286 |
| Change | - | -15.47% | -18.78% | -28.66% | -21.98% | 5.78% | -7.54% | -8.79% |
| P/E | 33.8x | 26x | 51.8x | -252x | -1.84x | 24.5x | 12.6x | 9.67x |
| PBR | 3.37x | 2.6x | 2.14x | 1.13x | 0.93x | 1.05x | 0.93x | 0.83x |
| PEG | - | 2.86x | -0.8x | 2x | -0x | -0x | 0.1x | 0.3x |
| Capitalization / Revenue | 3.68x | 3.01x | 2.21x | 1.09x | 0.59x | 0.73x | 0.71x | 0.68x |
| EV / Revenue | 4.35x | 3.64x | 2.99x | 2.04x | 1.57x | 1.62x | 1.45x | 1.28x |
| EV / EBITDA | 16.7x | 13.8x | 12.5x | 10.2x | 8.07x | 7.87x | 6.91x | 5.92x |
| EV / EBIT | 21.4x | 15.5x | 14x | 11.7x | 9.33x | 9.11x | 7.93x | 6.8x |
| EV / FCF | 25.4x | 25.5x | 63x | 132x | -82.5x | 11.8x | 18.2x | 14.8x |
| FCF Yield | 3.94% | 3.92% | 1.59% | 0.76% | -1.21% | 8.44% | 5.5% | 6.76% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.98 | 2.16 | 0.84 | -0.09 | -6.74 | 0.64 | 1.245 | 1.625 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,542 | 1,558 | 1,542 | 1,611 | 1,635 | 1,674 | 1,728 | 1,786 |
| EBITDA 1 | 400.7 | 411.3 | 369.7 | 322.2 | 317.5 | 344.3 | 363 | 385.9 |
| EBIT 1 | 314.1 | 366.6 | 329.1 | 281.1 | 274.8 | 297.6 | 315.9 | 336.3 |
| Net income 1 | 169.1 | 180.6 | 67.74 | -6.944 | -516.5 | 42.03 | 78.69 | 100.4 |
| Net Debt 1 | 1,033 | 986.7 | 1,200 | 1,535 | 1,596 | 1,489 | 1,285 | 1,064 |
| Reference price 2 | 66.99 | 56.07 | 43.55 | 22.68 | 12.42 | 15.71 | 15.71 | 15.71 |
| Nbr of stocks (in thousands) | 84,700 | 83,518 | 78,176 | 77,164 | 77,892 | 77,773 | - | - |
| Announcement Date | 23/02/22 | 22/02/23 | 28/02/24 | 25/02/25 | 26/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 24.55x | 1.62x | 7.87x | -.--% | 1.22B | ||
| 29.21x | 4.03x | 15.58x | 2.49% | 178B | ||
| 19.84x | 3.61x | 12.91x | 3% | 120B | ||
| 17.86x | 0.21x | 13.03x | 0.73% | 62.25B | ||
| 27.51x | 6.75x | 17.39x | 1.45% | 48.54B | ||
| 35.25x | 3.41x | 11.68x | 2.15% | 49.82B | ||
| 33.94x | 5.96x | 18.72x | -.--% | 31.95B | ||
| 42.07x | 1.24x | 11.48x | 0.22% | 28.59B | ||
| 41.42x | 7.26x | 26.04x | 0.25% | 25B | ||
| 16.86x | 2.69x | 9.53x | 1.64% | 21.59B | ||
| Average | 28.85x | 3.68x | 14.42x | 1.19% | 56.73B | |
| Weighted average by Cap. | 27.34x | 3.76x | 14.73x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IART Stock
- Valuation Integra LifeSciences Holdings Corporation
Select your edition
All financial news and data tailored to specific country editions
















